Late toxicity predictors in high-risk prostate cancer radiotherapy using accumulated delivered dose

被引：0

作者：

Ong, A. ^{[1
,2
]}

Panettieri, V. ^{[2
,3
]}

Dimmock, M. ^{[2
,4
]}

Tuan, J. ^{[1
]}

Tan, H. Q. ^{[1
]}

Wright, C. ^{[2
]}

机构：

[1] Natl Canc Ctr Singapore, Div Radiat Oncol, Singapore, Singapore

[2] Monash Univ, Dept Med Imaging & Radiat Sci, Clayton, Australia

[3] Alfred Hosp, Alfred Hlth Radiat Oncol, Melbourne, Australia

[4] Keele Univ, Sch Allied Hlth Profess, Keele, Staffs, England

来源：

RADIOTHERAPY AND ONCOLOGY | 2023年 / 182卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

PO-2118

引用

页码：S1905 / S1906

页数：2

共 50 条

[41] Prostate-specific antigen control with low-dose adjuvant radiotherapy for high-risk prostate cancer [J].

Macdonald, O. Kenneth ;

Lee, R. Jeffrey ;

Snow, Greg ;

Lee, Christopher M. ;

Tward, Jonathan D. ;

Middleton, Anthony W. ;

Middleton, George W. ;

Sause, William T. .

UROLOGY, 2007, 69 (02) :295-299

[42] Predictors of severe late urinary toxicity after curative radiotherapy for localised prostate cancer [J].

Takeda, K. ;

Takayama, Y. ;

Kadoya, N. ;

Takagi, H. ;

Ito, K. ;

Chiba, T. ;

Sato, K. ;

Dobashi, S. ;

Umezawa, R. ;

Yamamoto, T. ;

Ishikawa, Y. ;

Takeda, K. ;

Matsushita, H. ;

Kawasaki, Y. ;

Mitsuduka, K. ;

Jingu, K. .

RADIOTHERAPY AND ONCOLOGY, 2019, 133 :S823-S824

[43] Stereotactic pelvic radiotherapy with HDR boost for dose escalation in intermediate and high-risk prostate cancer (SPARE): Efficacy, toxicity and quality of life [J].

Musunuru, Hima Bindu ;

Cheung, Patrick ;

Vesprini, Danny ;

Liu, Stanley K. ;

Chu, William ;

Chung, Hans T. ;

Morton, Gerard ;

Deabreu, Andrea ;

Davidson, Melanie ;

Ravi, Ananth ;

Helou, Joelle ;

Ho, Ling ;

Zhang, Liying ;

Loblaw, Andrew .

RADIOTHERAPY AND ONCOLOGY, 2021, 161 :40-46

[44] Early and Late Complications after High Dose Rate Brachytherapy of Intermediate and High-Risk Prostate Cancer [J].

Ulys, A. ;

Burneckis, A. ;

Aleknavicius, E. ;

Vezelis, A. ;

Kasulaityte, L. .

UROLOGY, 2012, 80 (03) :S303-S303

[45] Anatomical Localization of Late Rectal Toxicity Predictors in Prostate Radiotherapy [J].

Foo, K. ;

Ebert, M. A. ;

Carolan, M. G. ;

Haworth, A. ;

Bulsara, M. ;

Joseph, D. ;

Denham, J. W. .

MEDICAL PHYSICS, 2013, 40 (06)

[46] Difference between planned and delivered radiotherapy dose to the internal mammary nodes in high-risk breast cancer patients [J].

Nielsen, Anders W. Molby ;

Spejlborg, Harald ;

Lutz, Christina Maria ;

Poulsen, Per Rugaard ;

Offersen, Birgitte Vrou .

PHYSICS & IMAGING IN RADIATION ONCOLOGY, 2023, 27

[47] Radiotherapy and hormone therapy in patients with high-risk prostate cancer [J].

Nature Clinical Practice Urology, 2008, 5 (1) :4-4

[48] Controversies in the therapy of high-risk prostate cancer. Radiotherapy [J].

Boehmer, D. .

ONKOLOGE, 2015, 21 (09) :805-+

[49] Neoadjuvant radiotherapy for locally advanced and high-risk prostate cancer [J].

Thoms, John ;

Goda, Jayant S. ;

Zlotta, Alexendre R. ;

Fleshner, Neil E. ;

van der Kwast, Theodorus H. ;

Supiot, St Phane ;

Warde, Padraig ;

Bristow, Robert G. .

NATURE REVIEWS CLINICAL ONCOLOGY, 2011, 8 (02) :107-113

[50] Radical Radiotherapy for High-Risk Prostate Cancer in Older Men [J].

Payne, Heather A. ;

Hughes, Simon .

ONCOLOGIST, 2012, 17 :9-15

← 1 2 3 4 5 →